Novo Nordisk creates AI division to help novel drug development

A new center in Seattle, US, will discover and develop new drugs using artificial intelligence. Recruitment for the new unit has begun.
Photo: Novo Nordisk / PR
Photo: Novo Nordisk / PR
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY DANIEL PEDERSEN

The use of artificial intelligence (AI) is gaining popularity within the healthcare sector, where the technology is used to optimize hospital scheduling, indentify at-risk patients, support decision-making tools and more.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading